Orchid Pharma Limited (BOM:524372)
India · Delayed Price · Currency is INR 522.10
+5.10 (0.99%)
At close: Apr 2, 2026
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 26.57 billion as of April 2, 2026. Its market cap has decreased by -40.03% in one year.
Market Cap
26.57B
Enterprise Value
27.90B
Revenue
8.11B
Ranking
n/a
PE Ratio
139.37
Stock Price
522.10
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 26.57B, an increase of 3,552.54%. That is a compound annual growth rate of 94.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 26.57B | -30.98% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 52.29B |
| Gufic Biosciences | 27.53B |
| Novartis India | 23.97B |
| Bliss GVS Pharma | 22.80B |
| Unichem Laboratories | 20.68B |
| Morepen Laboratories | 18.52B |
| Hikal | 18.13B |
| Amrutanjan Health Care | 14.31B |